Clearmind Medicine CMND

Clearmind submits FDA recommendations

Foreign issuer report

Form
6-K
Filed
Importance
Routine
  1. Submitted recommendations on psychedelic therapies
  2. Focused on non-hallucinogenic neuroplastogens
  3. Collaborated with FDA and U.S. government agencies

Written from the 6-K on EDGAR. Check the filing before you rely on it.

Get an email when Clearmind Medicine files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Same SIC code (2834) and public float not reported.